Madagascar vs Nigeria: Reported cases of paralytic polio by world region
Madagascar
24 cases
in 2023
Nigeria
87 cases
in 2023
Madagascar rank
5th
Nigeria rank
2nd
Reported cases of paralytic polio by world region over time
- Madagascar
- Nigeria
How they compare
Nigeria currently reports 87 cases against 24 cases in Madagascar, a difference of 63 cases.
That makes Nigeria's figure about 3.6 times Madagascar's.
The two have swapped places 2 times across 44 shared years of data; in 1980 it was Nigeria ahead.
Madagascar ranks 5th and Nigeria ranks 2nd of 199 countries.
Nigeria has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Madagascar | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 42.3 cases | 649.6 cases | 607.3 cases | Nigeria |
| 1990s | 11.6 cases | 831.4 cases | 819.8 cases | Nigeria |
| 2000s | 0.8 cases | 576.8 cases | 576 cases | Nigeria |
| 2010s | 1.1 cases | 42.4 cases | 41.3 cases | Nigeria |
| 2020s | 14 cases | 140.5 cases | 126.5 cases | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio by world region, Madagascar or Nigeria?
- Nigeria, at 87 cases against 24 cases in Madagascar as of 2023.
- What is the difference in reported cases of paralytic polio by world region between Madagascar and Nigeria?
- 63 cases, with Nigeria ahead.
- How many years of comparable data are there for Madagascar and Nigeria?
- 44 years are reported by both, from 1980 to 2023.
- How do Madagascar and Nigeria rank globally for reported cases of paralytic polio by world region?
- Madagascar ranks 5th and Nigeria ranks 2nd of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio by world region. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.